Daniel Judge to Heart Failure
This is a "connection" page, showing publications Daniel Judge has written about Heart Failure.
Connection Strength
2.281
-
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid?Cardiomyopathy. J Am Coll Cardiol. 2019 07 23; 74(3):285-295.
Score: 0.349
-
Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy. J Card Fail. 2017 Apr; 23(4):340-344.
Score: 0.299
-
Heart failure and genomics. J Am Coll Cardiol. 2007 Mar 13; 49(10):1106; author reply 1106-7.
Score: 0.151
-
The response to cardiac resynchronization therapy in LMNA cardiomyopathy. Eur J Heart Fail. 2022 04; 24(4):685-693.
Score: 0.107
-
Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic. Am Heart J. 2021 03; 233:122-131.
Score: 0.099
-
Multivalvular Pulsus Alternans. Circ Heart Fail. 2020 12; 13(12):e007134.
Score: 0.099
-
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study. Eur J Heart Fail. 2021 02; 23(2):277-285.
Score: 0.098
-
Endomyocardial Biopsy Characterization of Heart?Failure With Preserved Ejection?Fraction and Prevalence of Cardiac Amyloidosis. JACC Heart Fail. 2020 09; 8(9):712-724.
Score: 0.096
-
Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. J Am Heart Assoc. 2020 02 04; 9(3):e013695.
Score: 0.093
-
SSRI/SNRI Therapy is Associated With a Higher Risk of Gastrointestinal Bleeding in LVAD Patients. Heart Lung Circ. 2020 Aug; 29(8):1241-1246.
Score: 0.090
-
Genetic aetiologies should be considered in paediatric cases of acute heart failure presumed to be myocarditis. Cardiol Young. 2019 Jul; 29(7):917-921.
Score: 0.089
-
Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 10; 142(Suppl 2):S72-S81.
Score: 0.085
-
Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline. J Card Fail. 2018 May; 24(5):281-302.
Score: 0.082
-
Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circ Heart Fail. 2017 Sep; 10(9).
Score: 0.078
-
Giant Ring Mitochondria in a Patient With Heart Failure and Cerebral White Matter Disease Resulting From an MT-TL1 Mitochondrial Gene Mutation. J Card Fail. 2017 Aug; 23(8):652-655.
Score: 0.077
-
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices. J Heart Lung Transplant. 2017 Apr; 36(4):380-385.
Score: 0.075
-
Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis. J Cardiovasc Transl Res. 2015 Mar; 8(2):117-27.
Score: 0.066
-
Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2012 Jun; 9(6):961-7.
Score: 0.053
-
Intracardiac giant cells after left ventricular assist device placement. J Heart Lung Transplant. 2007 Apr; 26(4):417-20.
Score: 0.038
-
The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging. Heart Rhythm. 2006 Apr; 3(4):435-42.
Score: 0.036
-
Reversible cardiomyopathy caused by administration of interferon alpha. Nat Clin Pract Cardiovasc Med. 2005 Jan; 2(1):53-7.
Score: 0.033
-
Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular nodal block. Circulation. 2004 Nov 30; 110(22):3404-10.
Score: 0.032
-
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep 13; 379(11):1007-1016.
Score: 0.021
-
Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis. J Heart Lung Transplant. 2016 07; 35(7):868-76.
Score: 0.018
-
Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy. Heart. 2016 02 15; 102(4):303-12.
Score: 0.017